WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

Respiratory syncytial virus (RSV) is a globally prevalent cause of lower respiratory infection in neonates and infants. Despite its disease burden, a safe and effective RSV vaccine has remained elusive. In recent years, improved understanding of RSV biology and innovations in immunogen design has re...

Descripción completa

Detalles Bibliográficos
Autores principales: Modjarrad, Kayvon, Giersing, Birgitte, Kaslow, David C., Smith, Peter G., Moorthy, Vasee S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858870/
https://www.ncbi.nlm.nih.gov/pubmed/26100926
http://dx.doi.org/10.1016/j.vaccine.2015.05.093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858870/
https://www.ncbi.nlm.nih.gov/pubmed/26100926
http://dx.doi.org/10.1016/j.vaccine.2015.05.093

Ejemplares similares